Peijia Medical Limited (4WO) — Strategic Asset Allocation Index

Latest as of June 2023: 17.8%

Peijia Medical Limited (4WO) has a Strategic Asset Allocation Index of 17.8% as of June 2023. Strategic assets (PP&E of €436.11 Million plus long-term investments of €-) total €436.11 Million, measured against net assets of €2.44 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Peijia Medical Limited balance sheet quality to measure how much of total assets are equity-financed.

SAAI

17.8%
Strategic Assets / Net Assets

Strategic Assets

€436.11 Million
PP&E + LT Investments

PP&E

€436.11 Million
EUR

Net Assets

€2.44 Billion
EUR

Peijia Medical Limited Strategic Asset Allocation Index (2020–2021)

This chart shows how Peijia Medical Limited's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 17.8%, representing strategic assets of €436.11 Million against net assets of €2.44 Billion EUR. For live market cap and overall valuation, see 4WO stock market capitalisation.

Annual Strategic Asset Allocation Index for Peijia Medical Limited (2020–2021)

The table below presents the year-by-year Strategic Asset Allocation Index for Peijia Medical Limited from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 4WO book value for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (EUR) PP&E LT Investments Net Assets Change (pp)
2021 5.8% €176.22 Million €176.22 Million €- €3.02 Billion ▲ +2.0 pp
2020 3.8% €107.35 Million €107.35 Million €- €2.81 Billion
pp = percentage points